1. ARRB1-Promoted NOTCH1 Degradation Is Suppressed by OncomiR miR-223 in T-cell Acute Lymphoblastic Leukemia
- Author
-
Guang-Jie Jiang, Bi-Jie Yang, Bin Qu, Lin Zou, Wei Guo, Xinkun Qi, Wenqiong Lv, Yi Wang, Hai-Yan Liu, Zhidai Liu, Guo Fu, Fangjie Liu, Jun-Tao Yuan, Tong-Chuan He, Dan-Yi Peng, Yi Shu, Ke-Xing Wan, Linghuan Zhang, Penghui Zhang, Shan Liu, Hang Zhang, Shi Tang, Jie Yu, Yan-Hua Chen, Jia Zhang, Chao Yang, Juan Li, and Hui Zhao
- Subjects
Male ,0301 basic medicine ,Cancer Research ,Adolescent ,T cell ,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma ,Article ,Mice ,03 medical and health sciences ,0302 clinical medicine ,mir-223 ,Cell Line, Tumor ,microRNA ,medicine ,Animals ,Humans ,RNA-Seq ,Receptor, Notch1 ,Child ,3' Untranslated Regions ,Cell Proliferation ,Regulation of gene expression ,Gene Expression Regulation, Leukemic ,Chemistry ,Cell growth ,Tumor Suppressor Proteins ,Signal transducing adaptor protein ,Oncomir ,medicine.disease ,Xenograft Model Antitumor Assays ,MicroRNAs ,Leukemia ,beta-Arrestin 1 ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,Child, Preschool ,030220 oncology & carcinogenesis ,Proteolysis ,Cancer research ,Female ,Signal Transduction - Abstract
T-cell acute lymphoblastic leukemia (T-ALL) is a type of aggressive leukemia with inferior prognosis. Although activating mutations of NOTCH1 are observed in most T-ALL cases, these mutations alone are not sufficient to drive the full development of T-ALL. β-Arrestins (ARRB) are versatile and multifunctional adapter proteins that regulate diverse cellular functions, including promoting the development of cancer. However, the role of ARRBs in T-ALL has largely remained elusive. In this study, we showed that ARRB1 is expressed at low levels in assayed T-ALL clinical samples and cell lines. Exogenous ARRB1 expression inhibited T-ALL proliferation and improved the survival of T-ALL xenograft animals. ARRB1 facilitated NOTCH1 ubiquitination and degradation through interactions with NOTCH1 and DTX1. Mechanistically, the oncogenic miRNA (oncomiR) miR-223 targets the 3′-UTR of ARRB1 (BUTR) and inhibits its expression in T-ALL. Furthermore, overexpression of the ARRB1-derived miR-223 sponge suppressed T-ALL cell proliferation and induced apoptosis. Collectively, these results demonstrate that ARRB1 acts as a tumor suppressor in T-ALL by promoting NOTCH1 degradation, which is inhibited by elevated miR-223, suggesting that ARRB1 may serve as a valid drug target in the development of novel T-ALL therapeutics. Significance: These findings highlight a novel tumor suppressive function of the adaptor protein β-arrestin1 in T-ALL.
- Published
- 2020